Raynaud Disease

18 registered clinical trials studyying Raynaud Disease — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Multi-modal Quantitative Imaging of the Skin NCT06989216	HJN Sverige AB/Neko Health	—
Withdrawn	Phototherapy For Treatment Of Raynaud's Phenomenon NCT04898036	University of Minnesota	N/A
Terminated	Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Pheno NCT03869008	University of Toledo Health Science Campus	N/A
Completed	Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon NCT03699436	Universidad de Granada	N/A
Completed	Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phen NCT03094910	Herlev Hospital	N/A
Completed	Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud NCT03027674	Pontificia Universidad Catolica de Chile	EARLY_Phase 1
Completed	A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP) NCT02506062	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	N/A
Terminated	Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study NCT02642146	Seoul National University Hospital	—
Terminated	Metabolomic Analysis of Systemic Sclerosis NCT02298777	University Hospital, Strasbourg, France	—
Terminated	Exparel as a Nerve Block for Severe Hand Pain NCT02374320	Jose Soberon, MD	Phase 2 / Phase 3
Unknown	PORH and Response to Cold in Raynaud's Phenomenon. NCT02183779	University Hospital, Grenoble	N/A
Completed	Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator NCT01926847	Bayer	Phase 2
Completed	Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis. NCT01743612	University Hospital, Grenoble	N/A
Unknown	Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms NCT00934427	MediQuest Therapeutics	Phase 3
Completed	Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma NCT00626665	Sanjay Gandhi Postgraduate Institute of Medical Sciences	Phase 3
Completed	Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon NCT00251238	VSM Geneesmiddelen b.v.	Phase 2
Completed	Lab Study of MQX-503 in Treatment of Raynaud's NCT00253331	MediQuest Therapeutics	Phase 2 / Phase 3
Completed	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Seconda NCT00004786	National Center for Research Resources (NCRR)	Phase 3